[
    "{\"step_by_step_thinking\": \"The patient is experiencing severe, unremitting pain and has required escalating doses of oral morphine. This suggests that his current pain management strategy is not effective. The pain management team recommends using a medication that can reduce his opioid need through interaction with the NMDA-receptor. The most likely recommended agent for this purpose is ketamine, as it is known to have NMDA-receptor antagonist properties and can be used for pain management in cancer patients.\", \"answer_choice\": \"B. Ketamine\"}"
]